-
1
-
-
0345896723
-
Signaling in time and space: G protein-coupled receptors and mitogen-activated protein kinases
-
Luttrell D.K., and Luttrell L.M. Signaling in time and space: G protein-coupled receptors and mitogen-activated protein kinases. Assay Drug Dev. Technol. 1 (2003) 327-338
-
(2003)
Assay Drug Dev. Technol.
, vol.1
, pp. 327-338
-
-
Luttrell, D.K.1
Luttrell, L.M.2
-
2
-
-
0033553526
-
Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases
-
Della Rocca G.J., Maudsley S., Daaka Y., Lefkowitz R.J., and Luttrell L.M. Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases. J. Biol. Chem. 274 (1999) 13978-13984
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 13978-13984
-
-
Della Rocca, G.J.1
Maudsley, S.2
Daaka, Y.3
Lefkowitz, R.J.4
Luttrell, L.M.5
-
3
-
-
0033582343
-
Serotonin 5-HT1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosis
-
Della Rocca G.J., Mukhin Y.V., Garnovskaya M.N., Daaka Y., Clark G.J., Luttrell L.M., Lefkowitz R.J., and Raymond J.R. Serotonin 5-HT1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosis. J. Biol. Chem. 274 (1999) 4749-4753
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 4749-4753
-
-
Della Rocca, G.J.1
Mukhin, Y.V.2
Garnovskaya, M.N.3
Daaka, Y.4
Clark, G.J.5
Luttrell, L.M.6
Lefkowitz, R.J.7
Raymond, J.R.8
-
5
-
-
0038702295
-
'Location, location, location': activation and targeting of MAP kinases by G protein-coupled receptors
-
Luttrell L.M. 'Location, location, location': activation and targeting of MAP kinases by G protein-coupled receptors. J. Mol. Endocrinol. 30 (2003) 117-126
-
(2003)
J. Mol. Endocrinol.
, vol.30
, pp. 117-126
-
-
Luttrell, L.M.1
-
6
-
-
0035952645
-
New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades
-
Pierce K.L., Luttrell L.M., and Lefkowitz R.J. New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20 (2001) 1532-1539
-
(2001)
Oncogene
, vol.20
, pp. 1532-1539
-
-
Pierce, K.L.1
Luttrell, L.M.2
Lefkowitz, R.J.3
-
7
-
-
35848943698
-
Mitogenic signaling pathways induced by G protein-coupled receptors
-
Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J. Cell Physiol. 213 (2007) 589-602
-
(2007)
J. Cell Physiol.
, vol.213
, pp. 589-602
-
-
Rozengurt, E.1
-
8
-
-
0037458614
-
The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation
-
Tohgo A., Choy E.W., Gesty-Palmer D., Pierce K.L., Laporte S., Oakley R.H., Caron M.G., Lefkowitz R.J., and Luttrell L.M. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J. Biol. Chem. 278 (2003) 6258-6267
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 6258-6267
-
-
Tohgo, A.1
Choy, E.W.2
Gesty-Palmer, D.3
Pierce, K.L.4
Laporte, S.5
Oakley, R.H.6
Caron, M.G.7
Lefkowitz, R.J.8
Luttrell, L.M.9
-
9
-
-
61849179320
-
Development of LanthaScreen™ cellular assays for key components within the PI3K/AKT/mTOR pathway
-
Carlson C.B., Robers M.B., Vogel K.W., and Machleidt T. Development of LanthaScreen™ cellular assays for key components within the PI3K/AKT/mTOR pathway. J. Biomol. Screen. 14 (2009) 121-132
-
(2009)
J. Biomol. Screen.
, vol.14
, pp. 121-132
-
-
Carlson, C.B.1
Robers, M.B.2
Vogel, K.W.3
Machleidt, T.4
-
10
-
-
36148954308
-
High-throughput cellular assays for regulated posttranslational modifications
-
Robers M.B., Horton R.A., Bercher M.R., Vogel K.W., and Machleidt T. High-throughput cellular assays for regulated posttranslational modifications. Anal. Biochem. 372 (2008) 189-197
-
(2008)
Anal. Biochem.
, vol.372
, pp. 189-197
-
-
Robers, M.B.1
Horton, R.A.2
Bercher, M.R.3
Vogel, K.W.4
Machleidt, T.5
-
11
-
-
51849083849
-
Cellular LanthaScreen and beta-lactamase reporter assays for high-throughput screening of JAK2 inhibitors
-
Robers M.B., Machleidt T., Carlson C.B., and Bi K. Cellular LanthaScreen and beta-lactamase reporter assays for high-throughput screening of JAK2 inhibitors. Assay Drug Dev. Technol. 6 (2008) 519-529
-
(2008)
Assay Drug Dev. Technol.
, vol.6
, pp. 519-529
-
-
Robers, M.B.1
Machleidt, T.2
Carlson, C.B.3
Bi, K.4
-
12
-
-
8644290887
-
BacMam recombinant baculoviruses in G protein-coupled receptor drug discovery
-
Ames R., Fornwald J., Nuthulaganti P., Trill J., Foley J., Buckley P., Kost T., Wu Z., and Romanos M. BacMam recombinant baculoviruses in G protein-coupled receptor drug discovery. Receptors Channels 10 (2004) 99-107
-
(2004)
Receptors Channels
, vol.10
, pp. 99-107
-
-
Ames, R.1
Fornwald, J.2
Nuthulaganti, P.3
Trill, J.4
Foley, J.5
Buckley, P.6
Kost, T.7
Wu, Z.8
Romanos, M.9
-
13
-
-
34247533256
-
Implementation of BacMam virus gene delivery technology in a drug discovery setting
-
Kost T.A., Condreay J.P., Ames R.S., Rees S., and Romanos M.A. Implementation of BacMam virus gene delivery technology in a drug discovery setting. Drug Discov. Today 12 (2007) 396-403
-
(2007)
Drug Discov. Today
, vol.12
, pp. 396-403
-
-
Kost, T.A.1
Condreay, J.P.2
Ames, R.S.3
Rees, S.4
Romanos, M.A.5
-
14
-
-
4444284400
-
Recombinant baculoviruses used to study estrogen receptor function in human osteosarcoma cells
-
Clay W.C., Condreay J.P., Moore L.B., Weaver S.L., Watson M.A., Kost T.A., and Lorenz J.J. Recombinant baculoviruses used to study estrogen receptor function in human osteosarcoma cells. Assay Drug Dev. Technol. 1 (2003) 801-810
-
(2003)
Assay Drug Dev. Technol.
, vol.1
, pp. 801-810
-
-
Clay, W.C.1
Condreay, J.P.2
Moore, L.B.3
Weaver, S.L.4
Watson, M.A.5
Kost, T.A.6
Lorenz, J.J.7
-
15
-
-
0035994388
-
Titration of KATP channel expression in mammalian cells utilizing recombinant baculovirus transduction
-
Pfohl J.L., Worley III J.F., Condreay J.P., An G., Apolito C.J., Kost T.A., and Truax J.F. Titration of KATP channel expression in mammalian cells utilizing recombinant baculovirus transduction. Receptors Channels 8 (2002) 99-111
-
(2002)
Receptors Channels
, vol.8
, pp. 99-111
-
-
Pfohl, J.L.1
Worley III, J.F.2
Condreay, J.P.3
An, G.4
Apolito, C.J.5
Kost, T.A.6
Truax, J.F.7
-
16
-
-
5344251036
-
Influence of promoter choice and trichostatin A treatment on expression of baculovirus delivered genes in mammalian cells
-
Spenger A., Ernst W., Condreay J.P., Kost T.A., and Grabherr R. Influence of promoter choice and trichostatin A treatment on expression of baculovirus delivered genes in mammalian cells. Protein Expres. Purif. 38 (2004) 17-23
-
(2004)
Protein Expres. Purif.
, vol.38
, pp. 17-23
-
-
Spenger, A.1
Ernst, W.2
Condreay, J.P.3
Kost, T.A.4
Grabherr, R.5
-
17
-
-
8644284920
-
Heterologous expression of G protein-coupled receptors in U-2 OS osteosarcoma cells
-
Ames R., Nuthulaganti P., Fornwald J., Shabon U., van-der-Keyl H., and Elshourbagy N. Heterologous expression of G protein-coupled receptors in U-2 OS osteosarcoma cells. Receptors Channels 10 (2004) 117-124
-
(2004)
Receptors Channels
, vol.10
, pp. 117-124
-
-
Ames, R.1
Nuthulaganti, P.2
Fornwald, J.3
Shabon, U.4
van-der-Keyl, H.5
Elshourbagy, N.6
-
18
-
-
0031698286
-
35S]GTPgammaS binding study
-
35S]GTPgammaS binding study. Eur. J. Pharmacol. 355 (1998) 245-256
-
(1998)
Eur. J. Pharmacol.
, vol.355
, pp. 245-256
-
-
Newman-Tancredi, A.1
Gavaudan, S.2
Conte, C.3
Chaput, C.4
Touzard, M.5
Verriele, L.6
Audinot, V.7
Millan, M.J.8
-
19
-
-
0036828154
-
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes
-
Newman-Tancredi A., Cussac D., Quentric Y., Touzard M., Verriele L., Carpentier N., and Millan M.J. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes. J. Pharmacol. Exp. Ther. 303 (2002) 815-822
-
(2002)
J. Pharmacol. Exp. Ther.
, vol.303
, pp. 815-822
-
-
Newman-Tancredi, A.1
Cussac, D.2
Quentric, Y.3
Touzard, M.4
Verriele, L.5
Carpentier, N.6
Millan, M.J.7
-
20
-
-
0033983969
-
Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors
-
McLoughlin D.J., and Strange P.G. Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors. J. Neurochem. 74 (2000) 347-357
-
(2000)
J. Neurochem.
, vol.74
, pp. 347-357
-
-
McLoughlin, D.J.1
Strange, P.G.2
-
21
-
-
0030898020
-
Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats
-
Lejeune F., Newman-Tancredi A., Audinot V., and Millan M.J. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats. J. Pharmacol. Exp. Ther. 280 (1997) 1241-1249
-
(1997)
J. Pharmacol. Exp. Ther.
, vol.280
, pp. 1241-1249
-
-
Lejeune, F.1
Newman-Tancredi, A.2
Audinot, V.3
Millan, M.J.4
-
22
-
-
0015861774
-
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
-
Cheng Y., and Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
-
(1973)
Biochem. Pharmacol.
, vol.22
, pp. 3099-3108
-
-
Cheng, Y.1
Prusoff, W.H.2
-
23
-
-
33847025328
-
G protein-coupled receptor-mediated ERK1/2 phosphorylation: towards a generic sensor of GPCR activation
-
Leroy D., Missotten M., Waltzinger C., Martin T., and Scheer A. G protein-coupled receptor-mediated ERK1/2 phosphorylation: towards a generic sensor of GPCR activation. J. Recept. Signal. Transduct. Res. 27 (2007) 83-97
-
(2007)
J. Recept. Signal. Transduct. Res.
, vol.27
, pp. 83-97
-
-
Leroy, D.1
Missotten, M.2
Waltzinger, C.3
Martin, T.4
Scheer, A.5
-
24
-
-
58149183694
-
IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels
-
Harmar A.J., Hills R.A., Rosser E.M., Jones M., Buneman O.P., Dunbar D.R., Greenhill S.D., Hale V.A., Sharman J.L., Bonner T.I., Catterall W.A., Davenport A.P., Delagrange P., Dollery C.T., Foord S.M., Gutman G.A., Laudet V., Neubig R.R., Ohlstein E.H., Olsen R.W., Peters J., Pin J.P., Ruffolo R.R., Searls D.B., Wright M.W., and Spedding M. IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels. Nucleic Acids Res. 37 (2009) D680-D685
-
(2009)
Nucleic Acids Res.
, vol.37
-
-
Harmar, A.J.1
Hills, R.A.2
Rosser, E.M.3
Jones, M.4
Buneman, O.P.5
Dunbar, D.R.6
Greenhill, S.D.7
Hale, V.A.8
Sharman, J.L.9
Bonner, T.I.10
Catterall, W.A.11
Davenport, A.P.12
Delagrange, P.13
Dollery, C.T.14
Foord, S.M.15
Gutman, G.A.16
Laudet, V.17
Neubig, R.R.18
Ohlstein, E.H.19
Olsen, R.W.20
Peters, J.21
Pin, J.P.22
Ruffolo, R.R.23
Searls, D.B.24
Wright, M.W.25
Spedding, M.26
more..
-
25
-
-
33749521608
-
Latest development in drug discovery on G protein-coupled receptors
-
Lundstrom K. Latest development in drug discovery on G protein-coupled receptors. Curr. Protein Pept. Sci. 7 (2006) 465-470
-
(2006)
Curr. Protein Pept. Sci.
, vol.7
, pp. 465-470
-
-
Lundstrom, K.1
-
26
-
-
34447626644
-
GPCR functional selectivity has therapeutic impact
-
Mailman R.B. GPCR functional selectivity has therapeutic impact. Trends Pharmacol. Sci. 28 (2007) 390-396
-
(2007)
Trends Pharmacol. Sci.
, vol.28
, pp. 390-396
-
-
Mailman, R.B.1
-
27
-
-
0036258990
-
G protein-coupled receptor allosterism and complexing
-
Christopoulos A., and Kenakin T. G protein-coupled receptor allosterism and complexing. Pharmacol. Rev. 54 (2002) 323-374
-
(2002)
Pharmacol. Rev.
, vol.54
, pp. 323-374
-
-
Christopoulos, A.1
Kenakin, T.2
-
29
-
-
33845903110
-
Functional selectivity and classical concepts of quantitative pharmacology
-
Urban J.D., Clarke W.P., von Zastrow M., Nichols D.E., Kobilka B., Weinstein H., Javitch J.A., Roth B.L., Christopoulos A., Sexton P.M., Miller K.J., Spedding M., and Mailman R.B. Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol. Exp. Ther. 320 (2007) 1-13
-
(2007)
J. Pharmacol. Exp. Ther.
, vol.320
, pp. 1-13
-
-
Urban, J.D.1
Clarke, W.P.2
von Zastrow, M.3
Nichols, D.E.4
Kobilka, B.5
Weinstein, H.6
Javitch, J.A.7
Roth, B.L.8
Christopoulos, A.9
Sexton, P.M.10
Miller, K.J.11
Spedding, M.12
Mailman, R.B.13
-
30
-
-
0036208442
-
Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors
-
Holloway A.C., Qian H., Pipolo L., Ziogas J., Miura S., Karnik S., Southwell B.R., Lew M.J., and Thomas W.G. Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors. Mol. Pharmacol. 61 (2002) 768-777
-
(2002)
Mol. Pharmacol.
, vol.61
, pp. 768-777
-
-
Holloway, A.C.1
Qian, H.2
Pipolo, L.3
Ziogas, J.4
Miura, S.5
Karnik, S.6
Southwell, B.R.7
Lew, M.J.8
Thomas, W.G.9
-
31
-
-
41949089470
-
Beta-arrestin-biased agonism at the beta2-adrenergic receptor
-
Drake M.T., Violin J.D., Whalen E.J., Wisler J.W., Shenoy S.K., and Lefkowitz R.J. Beta-arrestin-biased agonism at the beta2-adrenergic receptor. J. Biol. Chem. 283 (2008) 5669-5676
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 5669-5676
-
-
Drake, M.T.1
Violin, J.D.2
Whalen, E.J.3
Wisler, J.W.4
Shenoy, S.K.5
Lefkowitz, R.J.6
-
32
-
-
34447649922
-
Beta-arrestin-biased ligands at seven-transmembrane receptors
-
Violin J.D., and Lefkowitz R.J. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol. Sci. 28 (2007) 416-422
-
(2007)
Trends Pharmacol. Sci.
, vol.28
, pp. 416-422
-
-
Violin, J.D.1
Lefkowitz, R.J.2
-
33
-
-
25444445236
-
Progress in lanthanides as luminescent probes
-
Hemmila I., and Laitala V. Progress in lanthanides as luminescent probes. J. Fluoresc. 15 (2005) 529-542
-
(2005)
J. Fluoresc.
, vol.15
, pp. 529-542
-
-
Hemmila, I.1
Laitala, V.2
-
34
-
-
0036085517
-
Principles and biophysical applications of lanthanide-based probes
-
Selvin P.R. Principles and biophysical applications of lanthanide-based probes. Annu. Rev. Biophys. Biomol. Struct. 31 (2002) 275-302
-
(2002)
Annu. Rev. Biophys. Biomol. Struct.
, vol.31
, pp. 275-302
-
-
Selvin, P.R.1
-
35
-
-
0032472195
-
Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter
-
Zlokarnik G., Negulescu P.A., Knapp T.E., Mere L., Burres N., Feng L., Whitney M., Roemer K., and Tsien R.Y. Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. Science 279 (1998) 84-88
-
(1998)
Science
, vol.279
, pp. 84-88
-
-
Zlokarnik, G.1
Negulescu, P.A.2
Knapp, T.E.3
Mere, L.4
Burres, N.5
Feng, L.6
Whitney, M.7
Roemer, K.8
Tsien, R.Y.9
-
36
-
-
40749112317
-
Optimization and utilization of the SureFire Phospho-STAT5 assay for a cell-based screening campaign
-
Binder C., Lafayette A., Archibeque I., Sun Y., Plewa C., Sinclair A., and Emkey R. Optimization and utilization of the SureFire Phospho-STAT5 assay for a cell-based screening campaign. Assay Drug Dev. Technol. 6 (2008) 27-37
-
(2008)
Assay Drug Dev. Technol.
, vol.6
, pp. 27-37
-
-
Binder, C.1
Lafayette, A.2
Archibeque, I.3
Sun, Y.4
Plewa, C.5
Sinclair, A.6
Emkey, R.7
-
37
-
-
45149121176
-
New strategies in drug discovery for GPCRs: high throughput detection of cellular ERK phosphorylation
-
Crouch M.F., and Osmond R.I. New strategies in drug discovery for GPCRs: high throughput detection of cellular ERK phosphorylation. Comb. Chem. High Throughput Screen. 11 (2008) 344-356
-
(2008)
Comb. Chem. High Throughput Screen.
, vol.11
, pp. 344-356
-
-
Crouch, M.F.1
Osmond, R.I.2
-
38
-
-
26944466076
-
GPCR screening via ERK 1/2: a novel platform for screening G protein-coupled receptors
-
Osmond R.I., Sheehan A., Borowicz R., Barnett E., Harvey G., Turner C., Brown A., Crouch M.F., and Dyer A.R. GPCR screening via ERK 1/2: a novel platform for screening G protein-coupled receptors. J. Biomol. Screen. 10 (2005) 730-737
-
(2005)
J. Biomol. Screen.
, vol.10
, pp. 730-737
-
-
Osmond, R.I.1
Sheehan, A.2
Borowicz, R.3
Barnett, E.4
Harvey, G.5
Turner, C.6
Brown, A.7
Crouch, M.F.8
Dyer, A.R.9
|